Close
Smartlab Europe
Achema middle east

News

Liver Health in the Age of Processed Foods: What Supplements Can Support Recovery

When it comes to nutrition, convenience can be demanding. The consumption of ultra-processed food has become a dietary norm because it is easily available and it is flavorful. However, new scientific research findings are becoming increasingly associated with liver...

Science-Backed Natural Weight Loss Methods That Actually Work

Weight loss is no longer about the ability to fit into smaller clothes but a matter of serious national health consideration. The World Health Organization estimates that the prevalence of obesity has nearly doubled during the last few decades,...

The Size of the Supplement Industry in Europe and How Fast it has Grown

The European supplement industry has transformed from a niche market serving fitness enthusiasts and health-conscious individuals into a mainstream economic powerhouse. Worth billions of euros and continuing its upward trajectory, this sector has become an integral component of Europe's...

Sanofi, Earendil Partner on Autoimmune Disease Treatments

Sanofi and Earendil Labs have announced a strategic collaboration effort that goes on to apply the discovery platform from Earendil across many of the Sanofi autoimmune and inflammatory disease programs. The two AI-powered research and development platforms from Earendil Labs concerning protein therapeutics go on...

Insilico and Servier Join Hands for New Oncology Therapies

Insilico Medicine has gone ahead with a multi-year research and development - R&D collaboration with Servier, of almost $888m, in order to develop and discover certain new oncology therapies. The partnership combines the AI drug discovery platforms of Insilico...

J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn

Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This move goes on to bring the Regulated Induced Proximity Targeting Chimera -RIPTAC platform from Halda to...

Celltrion Eyes Full-Scale Contract Manufacturing Operations

Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly that’s located in Branchburg, New Jersey, and is now entering full-scale contract manufacturing operations - CMO when it comes...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »